Clinical Trials Directory

Trials / Completed

CompletedNCT05837819

Methodology Issues in a Tailored Light Treatment for Persons With Dementia - Aim 2

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
135 (actual)
Sponsor
Icahn School of Medicine at Mount Sinai · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

Aim 2 will investigate the effect of 3 different light exposure lengths on sleep, mood and agitation in persons with Alzheimer's disease. Participants will be randomly assigned to one of three conditions of light exposure: 1) 2-h morning light exposure; 2) 4-h morning light exposure; and 3) all day light exposure.

Conditions

Interventions

TypeNameDescription
DEVICEActive Lighting InterventionLighting intervention using high light levels designed to effect the circadian system
DEVICEControl Lighting InterventionLighting intervention using low light levels designed to not effect the circadian system

Timeline

Start date
2023-02-14
Primary completion
2025-03-31
Completion
2025-03-31
First posted
2023-05-01
Last updated
2025-05-29

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05837819. Inclusion in this directory is not an endorsement.